-
UV Flu is committed to providing clean air to improve health and prevent the spread of disease. Its proven germicidal air purification technology removes and kills bacteria with more than 99% efficiency.
-
The Company's strategic differentiators include excellent independent test results proving the effectiveness and safety of its products, and proprietary design.
-
To drive growth UV Flu is working to gain market share selling to the U.S. commercial healthcare sector, pursue strategic alliances with medical product distributors, develop additional air quality products, and acquire companies and products with complementary offerings.
-
The Company has developed relationships with key hospital and nursing home administrators, medical equipment distributors and medical sales representatives.
-
The Company has filed U.S. Patent No. 6939397 with 43 claims covering its innovative removable cartridge, housing, UV chamber, UV radiation source and baffle technology.
-
UV Flu's products are environmentally friendly. The energy efficient system does not use or produce ozone, uses less energy than a 100 watt light bulb and can qualify for Green Building programs.